Tenax Therapeutics Provides Regulatory Update on Levosimendan
Go back to Tenax Therapeutics Provides Regulatory Update on Levosimendan| (NASDAQ: TENX) | Delayed: 1.72 +0.08 (4.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.64 | 52 Week High | $3.40 | |||
| Open | $1.62 | 52 Week Low | $1.34 | |||
| Day High | $1.76 | P/E | N/A | |||
| Day Low | $1.60 | EPS | $0.00 | |||
| Volume | 1,670,461 | |||||



